Founded in 1986, Menarini Biotech is part of the Menarini Group, Europe’s fastest growing, privately-owned biopharmaceutical company. MBH has over 25 years of experience in developing biotechnology products, giving us the perfect blend of expertise and experience from which our partners can benefit dealing with the development of production and supply processes of biotechnological drugs, produced from appropriately engineered mammalian cells, intended for clinical trials, in compliance with Good Manufacturing Practice, or GMP (Good Manufacturing Practice). Since 2005 and every three years, Menarini Biotech has been regularly inspected by the Italian Medicines Agency (AIFA) which has authorized the workshop for the production of drugs for clinical trials on humans.